"Ann Lewandowski, a healthcare policy and advocacy director at J&J ... accused the company of breaching its fiduciary duties to manage health benefit funds responsibly. In one instance, the complainant alleges that JNJ pays $10,200 for a multiple sclerosis drug called teriflunomide, which costs no more than $77 out of pocket at retail pharmacies." [Lewandowski v. Johnson & Johnson, No. 24-0671 (D.N.J. complaint filed Feb. 5, 2024)]  MORE >>